Related references
Note: Only part of the references are listed.Porous silicon nanoparticle as a stabilizing support for chondroitinase
Sara Daneshjou et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2017)
Identification of possible cytotoxicity mechanism of polyethylenimine by proteomics analysis
M. Khansarizadeh et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2016)
Towards a subcutaneous optical biosensor based on thermally hydrocarbonised porous silicon
Wing Yin Tong et al.
BIOMATERIALS (2016)
Ki-67 acts as a biological surfactant to disperse mitotic chromosomes
Sara Cuylen et al.
NATURE (2016)
Hyperthermic Laser Ablation of Recurrent Glioblastoma Leads to Temporary Disruption of the Peritumoral Blood Brain Barrier
Eric C. Leuthardt et al.
PLOS ONE (2016)
Crocin suppresses multidrug resistance in MRP overexpressing ovarian cancer cell line
Shadi Mahdizadeh et al.
DARU-JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Dual-drug delivery by porous silicon nanoparticles for improved cellular uptake, sustained release, and combination therapy
Chang-Fang Wang et al.
ACTA BIOMATERIALIA (2015)
Micelle-like Nanoparticles as Carriers for DNA and siRNA
Gemma Navarro et al.
MOLECULAR PHARMACEUTICS (2015)
Oligonucleotide delivery by chitosan-functionalized porous silicon nanoparticles
Morteza Hasanzadeh Kafshgari et al.
NANO RESEARCH (2015)
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Elvin Blanco et al.
NATURE BIOTECHNOLOGY (2015)
Stability, Intracellular Delivery, and Release of siRNA from Chitosan Nanoparticles Using Different Cross-Linkers
Maria Abdul Ghafoor Raja et al.
PLOS ONE (2015)
Small interfering RNA delivery by polyethylenimine-functionalised porous silicon nanoparticles
M. Hasanzadeh Kafshgari et al.
BIOMATERIALS SCIENCE (2015)
Inhibition of multidrug resistance protein 1 (MRP1) improves chemotherapy drug response in primary and recurrent glioblastoma multiforme
Amanda Tivnan et al.
FRONTIERS IN NEUROSCIENCE (2015)
Down-Regulation of MRP1 Expression in C6/VP16 Cells by Chitosan-MRP1-siRNA Nanoparticles
Haitao Xu et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2015)
Selective Optical Response of Hydrolytically Stable Stratified Si Rugate Mirrors to Liquid Infiltration
Tero Jalkanen et al.
ACS APPLIED MATERIALS & INTERFACES (2014)
Biodistribution of rhodamine B fluorescence-labeled cationic nanoparticles in rats
Kristina Bram Knudsen et al.
JOURNAL OF NANOPARTICLE RESEARCH (2014)
Cancer-targeting siRNA delivery from porous silicon nanoparticles
Yuan Wan et al.
NANOMEDICINE (2014)
Porous silicon nanoparticles for nanomedicine: preparation and biomedical applications
Helder A. Santos et al.
NANOMEDICINE (2014)
Construction and evaluation of controlled-release delivery system of Abamectin using porous silica nanoparticles as carriers
Yan Wang et al.
NANOSCALE RESEARCH LETTERS (2014)
Codelivery of an Optimal Drug/siRNA Combination Using Mesoporous Silica Nanoparticles To Overcome Drug Resistance in Breast Cancer in Vitro and in Vivo
Huan Meng et al.
ACS NANO (2013)
Co-delivery of a hydrophobic small molecule and a hydrophilic peptide by porous silicon nanoparticles
Dongfei Liu et al.
JOURNAL OF CONTROLLED RELEASE (2013)
EGFP-EGF1-Conjugated PLGA Nanoparticles for Targeted Delivery of siRNA into Injured Brain Microvascular Endothelial Cells for Efficient RNA Interference
Chen Chen et al.
PLOS ONE (2013)
Combination of siRNA-directed Gene Silencing With Cisplatin Reverses Drug Resistance in Human Non-small Cell Lung Cancer
Shanthi Ganesh et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2013)
Polyethylenimine-Based Amphiphilic Core-Shell Nanoparticles: Study of Gene Delivery and Intracellular Trafficking
Yuen Shan Siu et al.
BIOINTERPHASES (2012)
Functional Evidence of Multidrug Resistance Transporters (MDR) in Rodent Olfactory Epithelium
Adrien Molinas et al.
PLOS ONE (2012)
Proliferative and Nonproliferative Lesions of the Rat and Mouse Urinary System
Kendall S. Frazier et al.
TOXICOLOGIC PATHOLOGY (2012)
The appearance of renal cells cytoplasmic degeneration and nuclear destruction might be an indication of GNPs toxicity
Mohamed Anwar K. Abdelhalim et al.
LIPIDS IN HEALTH AND DISEASE (2011)
Combined Use of Anticancer Drugs and an Inhibitor of Multiple Drug Resistance-Associated Protein-1 Increases Sensitivity and Decreases Survival of Glioblastoma Multiforme Cells In Vitro
Lilia Peignan et al.
NEUROCHEMICAL RESEARCH (2011)
Nanostructured mesoporous silica matrices in nanomedicine
M. Vallet-Regi
JOURNAL OF INTERNAL MEDICINE (2010)
siRNA applications in nanomedicine
Talar Tokatlian et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2010)
Small-Molecule Multidrug Resistance-Associated Protein 1 Inhibitor Reversan Increases the Therapeutic Index of Chemotherapy in Mouse Models of Neuroblastoma
Catherine A. Burkhart et al.
CANCER RESEARCH (2009)
Origins and Mechanisms of miRNAs and siRNAs
Richard W. Carthew et al.
CELL (2009)
Mrp1 Localization and Function in Cardiac Mitochondria after Doxorubicin
Paiboon Jungsuwadee et al.
MOLECULAR PHARMACOLOGY (2009)
The Effect of Chemical Modification and Nanoparticle Formulation on Stability and Biodistribution of siRNA in Mice
Shan Gao et al.
MOLECULAR THERAPY (2009)
Mesoporous silicon in drug delivery applications
Jarno Salonen et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer
Maha Saad et al.
NANOMEDICINE (2008)
Stability Study of Unmodified siRNA and Relevance to Clinical Use
Robyn P. Hickerson et al.
OLIGONUCLEOTIDES (2008)
Role of the MRP1/ABCC1 multidrug transporter protein in cancer
Marcia Munoz et al.
IUBMB LIFE (2007)
A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer
R. O'Connor et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
RNAi therapeutics: a potential new class of pharmaceutical drugs
David Bumcrot et al.
NATURE CHEMICAL BIOLOGY (2006)
An approach to duodenal biopsies
S. Serra et al.
JOURNAL OF CLINICAL PATHOLOGY (2006)
The functions and structure of ABC transporters: Implications for the design of new inhibitors of Pgp and MRP1 to control multidrug resistance (MDR)
E. Teodori et al.
CURRENT DRUG TARGETS (2006)
Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging
DW Bartlett et al.
NUCLEIC ACIDS RESEARCH (2006)
Multidrug resistance-associated proteins: Expression and function in the central nervous system
Shannon Dallas et al.
PHARMACOLOGICAL REVIEWS (2006)
Stabilization of porous silicon surface by thermal decomposition of acetylene
J Salonen et al.
APPLIED SURFACE SCIENCE (2004)
Glioblastoma cells release factors that disrupt blood-brain barrier features
SW Schneider et al.
ACTA NEUROPATHOLOGICA (2004)
Involvement of multidrug resistance associated protein 1 (Mrp1) in the efflux transport of 17β estradiol-D-17β-glucuronide (E217βG) across the blood-brain barrier
D Sugiyama et al.
PHARMACEUTICAL RESEARCH (2003)
Thermal hydrosilylation of undecylenic acid with porous silicon
R Boukherroub et al.
JOURNAL OF THE ELECTROCHEMICAL SOCIETY (2002)
In vitro and in vivo downregulation of MRP1 by antisense oligonucleotides: A potential role in neuroblastoma therapy
BJ Kuss et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Molecular characterization of cell substratum attachments in human glial tumors relates to prognostic features
N Belot et al.
GLIA (2001)
MRP1 gene expression level regulates the death and differentiation response of neuroblastoma cells
AE Peaston et al.
BRITISH JOURNAL OF CANCER (2001)
Histone H3 phosphorylation and cell division
F Hans et al.
ONCOGENE (2001)
The structure of the multidrug resistance protein 1 (MRP1/ABCC1) - Crystallization and single-particle analysis
MF Rosenberg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Cantilever-based optical deflection assay for discrimination of DNA single-nucleotide mismatches
KM Hansen et al.
ANALYTICAL CHEMISTRY (2001)
Regulation of expression of the multidrug resistance protein MRP1 by p53 in human prostate cancer cells
GF Sullivan et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Expression of multidrug resistance-associated protein (MRP) in human gliomas
M Mohri et al.
JOURNAL OF NEURO-ONCOLOGY (2000)
Share Paper
